$11.16
9.56% yesterday
Nasdaq, Dec 19, 10:17 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US88688T1007
Symbol
TLRY

Tilray, Inc. Series 2 Stock News

Neutral
Seeking Alpha
about 6 hours ago
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens.
Positive
CNBC
about 8 hours ago
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targeted polling, according to industry insiders. Trulieve CEO Kim Rivers and Palm Beach billionaire Howard Kessler leveraged personal ties, fundraisers and political spending to press the White House, ...
Positive
Market Watch
about 10 hours ago
Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities.
Positive
The Motley Fool
about 10 hours ago
Tilray Brands' stock performance hinges on the outlook for marijuana reform in the U.S. President Trump is considering rescheduling marijuana, which has investors bullish on Tilray of late. The company's financial results, however, show that marijuana revenue declined in its most recent fiscal year.
Negative
The Motley Fool
about 12 hours ago
Investors felt the cannabis executive order didn't go far enough. Tilray's CEO backed President Trump's decision, but called it an "incremental step.
Positive
New York Post
about 15 hours ago
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Neutral
Invezz
about 24 hours ago
President Donald Trump's move to relax federal marijuana regulations has been welcomed by the US cannabis industry, but it has not changed the sector's most persistent challenge. Access to mainstream banking remains limited, even as regulatory pressure eases, reports Reuters.
Negative
Reuters
one day ago
U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.
Show more news

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today